Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Finance Online.
Press releases published on April 4, 2025
Pender Growth Fund Provides Financial Highlights and Company Updates
GlobeNewswire
·
April 4, 2025
VANCOUVER, British Columbia, April 04, 2025 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the year ended December 31, 2024. Financial Highlights Net income was $55,473,592 …
First Federal Savings Bank Awards $27,500 in Funds to Habitat for Humanity Through FHLBank Indianapolis Grant Program
GlobeNewswire
·
April 4, 2025
EVANSVILLE, Ind., April 04, 2025 (GLOBE NEWSWIRE) -- First Federal Savings Bank, a member bank of the Federal Home Loan Bank of Indianapolis (FHLBank Indianapolis), awarded Habitat for Humanity $27,500 in grant funds through the Community Multiplier – …
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
GlobeNewswire
·
April 4, 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
GlobeNewswire
·
April 4, 2025
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …
PIMCO Closed-End Funds Announce Proposed Reorganizations
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of each of the following funds has approved the following proposals to reorganize the PIMCO closed-end municipal funds (each, a “Merger” and collectively, the “Mergers”), subject to the …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Beyond Oil Announces Distribution Agreement in the Netherlands with Mandarin Food Products
GlobeNewswire
·
April 4, 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing health risks associated with fried …
USCB Financial Holdings, Inc. to Announce First Quarter 2025 Results
GlobeNewswire
·
April 4, 2025
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended March 31, 2025 after the market closes on Thursday, April 24, 2025. A conference call to discuss …
Glacier Bancorp, Inc. Announces First Quarter Earnings Release and Conference Call
GlobeNewswire
·
April 4, 2025
KALISPELL, Mont., April 04, 2025 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI) will report first quarter financial results after the market closes on April 24, 2025. A conference call for investors is scheduled for 11:00 a.m. Eastern Time on …
Far Niente Steps Up to the Plate as Proud Partner of the San Francisco Giants
GlobeNewswire
·
April 4, 2025
Oakville, CA, April 04, 2025 (GLOBE NEWSWIRE) -- Far Niente Wine Estates, one of Napa Valley’s most venerated wine houses, is delighted to announce it will bring its portfolio to Oracle Park as a proud partner of the San Francisco Giants. Beginning this …
ThinkCareBelieve: Week 11 America Under President Trump's Leadership
GlobeNewswire
·
April 4, 2025
Washington DC, April 04, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/03/31/week-11-under-president-trumps-leadership/ What an amazing week this has been. So many huge strides made. ThinkCareBelieve has …
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for First Quarter 2025
GlobeNewswire
·
April 4, 2025
STAMFORD, Conn., April 04, 2025 (GLOBE NEWSWIRE) -- Grayscale Investments®, a leading crypto asset management firm, offering more than 30 crypto investment products, and manager of Grayscale® Digital Large Cap Fund (OTCQX: GDLC) (Digital Large Cap Fund), …
CV Holdings, Inc. Update and Financial Statements for Year Ended December 31, 2024
GlobeNewswire
·
April 4, 2025
NEWPORT BEACH, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- CV Holdings, Inc. (OTC Pink Limited: CVHL) (the “Company”) today reported a net loss for the year ended December 31, 2024 of $(18,153,285) or $(0.28) per common share with weighted average common …
National Bank Holdings Corporation Announces Date for 2025 First Quarter Earnings Release
GlobeNewswire
·
April 4, 2025
DENVER, April 04, 2025 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) expects to report its first quarter financial results after the markets close on Tuesday, April 22, 2025. Management will host a conference call to review the …
Triumph Financial Announces Schedule for First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 4, 2025
DALLAS, April 04, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its first quarter financial results and management commentary after the market closes on Wednesday, April 16, 2025. Upon filing, …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Wintrust Financial Corporation Announces Cash Dividends
GlobeNewswire
·
April 4, 2025
ROSEMONT, Ill., April 04, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq: WTFC) today announced that the Company’s Board of Directors approved a quarterly cash dividend of $0.50 per share of outstanding common …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on March 31, 2025, the company granted equity awards to three new employees …